The End is Near: DCAA Projects End of Incurred Cost Backlog by FY 2018
Client Alert | 1 min read | 06.11.18
The Defense Contract Audit Agency (DCAA) recently made public its Fiscal Year 2017 Report to Congress, which, among other things, provides an update on incurred cost audits. According to DCAA, it is “on track to eliminate the backlog by the close of FY 2018” as it now has “under 3,000 incurred cost years in [such] backlog….” However, it is important to remember that DCAA does not consider an audit backlogged unless it is “older than two fiscal years.”
The report also covers other aspects of incurred cost audits (e.g., sustained audit exceptions), which are discussed more fully in our blog post on the topic.
Contacts
Insights
Client Alert | 9 min read | 10.21.26
The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .
Client Alert | 2 min read | 10.21.26
Client Alert | 3 min read | 10.21.26
Private Investigations Act Series: Temporal, material and territorial scope
Client Alert | 7 min read | 10.21.26
